Merit Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55M Buy
45,883
+2,324
+5% +$2.37M 0.34% 59
2026
Q1
$40.1M Buy
43,559
+5,525
+15% +$5.6M 0.3% 71
2025
Q4
$40.9M Buy
38,034
+3,565
+10% +$3.41M 0.33% 61
2025
Q3
$26.3M Buy
34,469
+2,039
+6% +$1.52M 0.24% 82
2025
Q2
$25.3M Buy
32,430
+7,127
+28% +$5.54M 0.28% 67
2025
Q1
$20.9M Buy
25,303
+4,752
+23% +$3.95M 0.31% 59
2024
Q4
$15.9M Buy
20,551
+6,307
+44% +$5.22M 0.29% 67
2024
Q3
$12.6M Sell
14,244
-1,371
-9% -$1.23M 0.28% 61
2024
Q2
$14.1M Buy
15,615
+2,553
+20% +$2.04M 0.31% 56
2024
Q1
$9.6M Buy
13,062
+8,528
+188% +$6.07M 0.23% 77
2023
Q4
$2.64M Sell
4,534
-5,024
-53% -$2.93M 0.08% 164
2023
Q3
$5.13M Buy
9,558
+234
+3% +$121K 0.17% 96
2023
Q2
$4.37M Buy
9,324
+1,624
+21% +$681K 0.14% 110
2023
Q1
$2.64M Buy
7,700
+1,601
+26% +$540K 0.1% 164
2022
Q4
$2.23M Buy
6,099
+1,183
+24% +$419K 0.08% 182
2022
Q3
$1.59M Sell
4,916
-4,089
-45% -$1.3M 0.07% 186
2022
Q2
$2.92M Buy
9,005
+8,270
+1,125% +$2.48M 0.09% 138
2022
Q1
$210K Buy
+735
New +$189K 0.01% 362

Other funds holding LLY

Merit Financial Group's LLY Position: Q2 2026 in Review

Merit Financial Group increased its Eli Lilly (LLY) stake by 5.3% in Q2 2026, buying an estimated $2.37M and bringing the position to 45,883 shares worth $55M. The position accounts for 0.34% of the portfolio, ranked #59.

Merit Financial Group first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Merit Financial Group held 45,883 shares of Eli Lilly worth $55M as of Q2 2026.
  • Merit Financial Group bought 2,324 Eli Lilly shares in Q2 2026, an estimated $2.37M.
  • Eli Lilly made up 0.34% of Merit Financial Group's portfolio in Q2 2026, its #59 holding.
  • Merit Financial Group first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.